series-b
Stage
1
Investors
About
Cardurion Pharmaceuticals develops therapeutics targeting cardiovascular diseases by focusing on PDE9 inhibition for heart failure and CaMKII inhibition for arrhythmias and other cardiac conditions.
Explore Cardurion Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.